1. Home
  2. ENSG vs RGEN Comparison

ENSG vs RGEN Comparison

Compare ENSG & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSG
  • RGEN
  • Stock Information
  • Founded
  • ENSG 1999
  • RGEN 1981
  • Country
  • ENSG United States
  • RGEN United States
  • Employees
  • ENSG N/A
  • RGEN N/A
  • Industry
  • ENSG Hospital/Nursing Management
  • RGEN Medical/Dental Instruments
  • Sector
  • ENSG Health Care
  • RGEN Health Care
  • Exchange
  • ENSG Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • ENSG 7.3B
  • RGEN 8.0B
  • IPO Year
  • ENSG 2007
  • RGEN N/A
  • Fundamental
  • Price
  • ENSG $149.15
  • RGEN $118.15
  • Analyst Decision
  • ENSG Buy
  • RGEN Buy
  • Analyst Count
  • ENSG 7
  • RGEN 12
  • Target Price
  • ENSG $164.71
  • RGEN $172.67
  • AVG Volume (30 Days)
  • ENSG 441.3K
  • RGEN 819.3K
  • Earning Date
  • ENSG 04-29-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • ENSG 0.17%
  • RGEN N/A
  • EPS Growth
  • ENSG 39.72
  • RGEN N/A
  • EPS
  • ENSG 5.30
  • RGEN N/A
  • Revenue
  • ENSG $4,423,354,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • ENSG $17.71
  • RGEN $13.93
  • Revenue Next Year
  • ENSG $9.69
  • RGEN $14.35
  • P/E Ratio
  • ENSG $27.22
  • RGEN N/A
  • Revenue Growth
  • ENSG 14.81
  • RGEN 4.88
  • 52 Week Low
  • ENSG $116.23
  • RGEN $102.97
  • 52 Week High
  • ENSG $158.45
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • ENSG 78.91
  • RGEN 38.20
  • Support Level
  • ENSG $129.91
  • RGEN $120.11
  • Resistance Level
  • ENSG $133.08
  • RGEN $129.42
  • Average True Range (ATR)
  • ENSG 3.73
  • RGEN 6.02
  • MACD
  • ENSG 1.99
  • RGEN -1.20
  • Stochastic Oscillator
  • ENSG 98.79
  • RGEN 5.96

About ENSG The Ensign Group Inc.

Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: